SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ciphergen Biosystems(CIPH):
An SI Board Since September 2000
Posts SubjectMarks Bans
510 15 0
Emcee:  mact Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
285Invitrogen Corporation Licenses Key Protein Chip Intellectual Property from Zyomnigel bates-11/30/2004
284[Enhancement of Sensitivity and Resolution of SELDI Using Time-Series Analysis] tuck-11/30/2004
283[Proteomic Fingerprints for Early Diagnosis of SARS] >>Clin Chem. 2004 Notuck-11/30/2004
282>>CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 18, 2004-- Invitrogen Corporatiotuck-11/18/2004
281[Discovery of laryngeal carcinoma by serum proteomic pattern analysis] >>tuck-11/6/2004
280CIPH makes eps estimate, but revenues a little light. No obvious traction with tuck-11/2/2004
279[SELDI & human immunodeficiency virus type 1 associated dementia] >>Jtuck-10/31/2004
278Not bad. They bought BioSepra for $12 million, so they actually made a profit, tuck-10/28/2004
277Ciphergen Biosystems Announces Sale of BioSepra Process Chromatography Thursday nigel bates-10/28/2004
276<i>Zyomyx...</i> $100 Million in State-of-the-Art Biotechnology andnigel bates-10/26/2004
275BD BioSciences attempts to compete in protein expression with their PowerBlot sytuck-10/18/2004
274The Scientist reviews the new system: the-scientist.com Reproducibility from mtuck-10/11/2004
273Listened to Matt Hogan on the UBS presentation. Clinical milestones upcoming attuck-10/8/2004
272Ciphergen Presents Promising Validation Results for Ovarian Cancer Biomarkers atnigel bates-10/6/2004
271Drug Discovery & Development's lead article is on biomarkers. No mentiotuck-10/4/2004
270"An integrated approach to the detection of colorectal cancer utilizing protuck-10/3/2004
269>>Protein Profiling of Microdissected Prostate Tissue Links Growth Differetuck-9/7/2004
268>>Characterization of the microheterogeneity of transthyretin in plasma antuck-9/6/2004
267Ciphergen will have a noticeable presence at the 2nd Annual Protein Biomarkers Ctuck-8/26/2004
266Arghh. Going in circles. What I get for reading too much into Yahoo posters antuck-8/25/2004
265The full text of that article is a freebie, it turns out. And interestingly, thtuck-8/24/2004
264[Correlogic test with hi-res mass spec] From the June 2004 issue of Endocrine Rtuck-8/24/2004
263[Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of tuck-8/24/2004
262>>I think the nearness of their direct competitors is a bit overstated.<tuck-8/23/2004
261Piper Ciphergen (CIPH - $2.71) Underperform Volatility: Medium Price mopgcw-8/20/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News